The study, known as the Vagina and Oral Interventions to Control the Epidemic, involves common drugs like Tenofovir and Truvada. Study director Dr Nyaradzo Mugodhi said after 22,5 months, researchers would be able to tell if the ARVs are effective in preventing HIV transmission when taken daily.

 

"Since the launch of the study late last year, we have so far recruited 192 women to participate, accounting for a third of our target," Dr Mugodhi said.

 

Meanwhile, to strengthen these research programmes, HIV prevention researchers, policy makers and community advocates from more than 35 countries will be in the United States from May 22 to 25 to share their knowledge.

 

"It will also be a forum for discussions on male circumcision, pre-exposure prophylaxis and vaccines," said Lisa Rossi, MTN director of communications

 

Source: allAfrica